Table 2.
Paper | Diagnosis | Intellectual Disability |
n (ASD) | Mean age (years) |
Gender | Medication | Site | Coil | Frequency | Intensity | Duration |
---|---|---|---|---|---|---|---|---|---|---|---|
Sokhadze et al. [2009], Journal of Autism and Developmental Disorders (RCT with waitlist control) |
Autism | None | 13 (8rTMS, 5 waitlist) |
17 | M | – | L dlPFC (5cm anterior to M1) |
Fo8 | 0.5 Hz | 90% RMT | 10 min |
Baruth et al. [2010], Journal of Neurotherapy (RCT with waitlist control) |
ASD | 2 | 25 (16rTMS, 9 waitlist) |
14 | M/F | – | L & R dlPFC (5cm ante- rior to M1) |
Fo8 | 1 Hz | 90% RMT | 10 min |
Sokhadze et al. [2010], Applied Psychophysiology and Biofeedback (Clinical trial with no control) |
Autism | None | 13 | 16 | M/F | – | L dlPFC (5cm anterior to M1) |
Fo8 | 0.5 Hz | 90% RMT | 10 min |
Enticott et al. [2011], Journal of ECT (Single case study) |
AS | None | 1 | 20 | F | None | Bilateral dmPFC (7cm anterior to M1) |
H-coil | 5 Hz | 100% RMT | 15 min |
Fecteau et al. [2011], European Journal of Neuroscience (Crossover trial with sham control) |
AS | None | 10 | 37 | M/F | None | L & R pars opercularis, L & R par triangularis (MRIneuronaviga tion), sham (central lobe midline) |
Fo8 | 1 Hz | 70% of stimulator output |
30 min |
Casanova et al. [2012], Translational Neuroscience (RCT with waitlist control) |
ASD | None | 45 (25 rTMS, 20 waitlist) |
13 | M/F | - | L & R dlPFC (5cm ante- rior to M1) |
Fo8 | 1 Hz | 90% RMT | 10 min |
Enticott et al. [2012], Brain Stimulation (Crossover trial with sham control) |
ASD (6 HFA, 5 AS) |
None | 11 | 18 | M/F | - | SMA (15%of nasion to inion anterior to Cz), L M1, Sham (M1) |
Fo8 | 1 Hz | 100% RMT | 15 min |
Niederhofer [2012], Clinical Neuropsychiatry (Single case study with placebo) |
Autism | Not reported | 1 | 42 | F | None | M1 | – | 1 Hz | – | 1 hr |
Sokhadze et al. [2012], Applied Psychophysiology and Biofeedback (RCT with waitlist control) |
ASD (36 HFA, 4 AS) |
None | 40 (20 rTMS, 20 waitlist) |
14 | M/F | – | L & R dlPFC (5cm ante- rior to M1) |
Fo8 | 1 Hz | 90% RMT | 10 min |
Panerai et al. [2013], Autism ((i) Crossover trial with sham; (ii) RCT with sham; (iii) crossover trial with sham iv) RCT (TMS, EHI training, TMS + EHI training)) |
Autism | Severe to profound |
(i) 9 (ii) 17 (iii) 4 (iv) 13 |
(i) 14 (ii) 13 (iii) 16 (iv) 13 |
M | – | (i) left and right PrMC (2.5 cm anterior to M1) (ii), (iii), iv) left PrMC |
Fo8 | (i) 8 Hz, 1 Hz (ii) 8 Hz, 1 Hz (iii), (iv) 8 Hz |
90% RMT | 8 Hz 30 min, 1 Hz 15 min; |
Enticott et al. [2014], Brain Stimulation (RCT with sham control) |
ASD (4 HFA, 24 AS) |
None | 28 (15active, 13 sham) |
33 | M/F | Yes (39%) | dmPFC (7cm anterior to M1) |
H-coil | 5 Hz | 100% RMT | 15 min |
Cristancho et al. [2014], Journal of ECT (Single case study) |
Autism, Depression |
Not reported | 1 | 15 | M | olanzapine, fluoxetine, guanfacine, clonazepam |
(i) R DLPFC (6cm anterior to M1), (ii) L DLPFC (6cm anterior to M1) |
Fo8 | 1 Hz | 0% RMT | Variable (between 5 to 25 min) |
Casanova et al. [2014], Frontiers in Human Neuroscience (Proof of feasibility study, no control) |
ASD | None | 18 | 13 | M/F | – | L & R dlPFC (5cm ante- rior to M1) |
Fo8 | 5 Hz | 90% RMT | 10 min |
Sokhadze et al. [2014a], Frontiers in Systems Neuroscience (RCL with waitlist control) |
ASD | None | 27 | 14.5 | M/F | – | L & R dlPFC (5cm ante- rior to M1) |
Fo8 | 1 Hz | 90% RMT | 10 min |
Sokhadze et al. [2014b], Appl Psychophysiol Biofeedback (Clinical trial with waitlist control) |
ASD | None | 42 | 14.5 | M/F | – | L & R dlPFC (5cm ante- rior to M1) |
Fo8 | 1 Hz | 90% RMT | 10 min |
Paper | Trains | Pulses Delivered |
Sessions | Blinding | Measures | Assessment Times | Reported Effects | Side Effects |
---|---|---|---|---|---|---|---|---|
Sokhadze et al. [2009], Journal of Autism and Developmental Disorders |
15 × 10 sec, 20–30 sec ISI |
150 | 6 | None | EEG Gamma power Accuracy, RT (Kanizsa), Abberant Behavior Checklist (ABC), Social Responsiveness Scale (SRS) (Caregiver- report), Repetitive Behavior Scale- Revised (RBS-R) |
Before and two weeks after treat- ment course |
Decreased frontal EEG P3a amplitude to non-targets following TMS Decreased centro-parietal latency EEG P3b to nontarget and non- Kanizsa following TMS Decrease in gamma power for non- target and non-Kanizsa following TMS Reduced repetitive behavior (RBS-R) following TMS |
– |
Baruth et al. [2010], Journal of Neurotherapy |
15 × 10 sec, 20–30 s ISI |
150 | 12 (6 L, 6 R) | None | EEG Gamma power Accuracy, RT (Kanizsa), Abberant Behavior Checklist (ABC), Social Responsiveness Scale (SRS) (Caregiver- report), Repetitive Behavior Scale- Revised (RBS-R) |
Before and two weeks after treat- ment course |
Increased EEG gamma power to tar- gets, decrease to nontargets Reduced repetitive behavior (RBS-R) Reduced irritability (ABC) |
Itching sensation at nose (5) Mild headache (1) |
Sokhadze et al. [2010], Applied Psychophysi- ology and Biofeedback |
15 × 10 sec, 20–30 sec ISI |
150 | 6 | None | EEG event-related potentials (visual oddball) Accuracy, RT (Kanizsa) Abberant Behavior Checklist (ABC) Social Responsiveness Scale (SRS) (Caregiver- report) Repetitive Behavior Scale-Revised (RBS-R) |
Before and two weeks after treat- ment course |
Reduced error rate Increased frontal EEG P50 amplitude to targets Increased frontal EEG P50 latency to targets Decreased frontal EEG N200 latency to novel distractors Decreased parieto-occipital EEG P50 to novel distractor Increased centro-parietal EEG P50 to targets and decreased to standard distractor Centro-parietal EEG P3b amplitude increase to targets and decrease to standard distractors Centro-parietal EEG P200 increased latency to targets Reduced repetitive behaviors (RBS- R) |
– |
Enticott et al. [2011], Journal of ECT |
30 × 10 sec, 20 sec ISI |
1500 | 10 | Double | IRI, AQ, RAADS | Before, after, and one-month after treatment course |
Reduction on all measures Anecdotal reports of improvement from patient and relatives |
None |
Fecteau et al. [2011], European Journal of Neuroscience |
1 | 1800 | 1 per site | Double | Response latency on Boston Naming Test |
Before and after TMS | Increased response latency after L pars opercularis Decreased response latency after L pars triangularis |
Many reported, including: Sleepy, Trouble concen- trating, Improved mood, Headache, Dizziness |
Casanova et al. [2012], Translational Neuroscience |
15 × 10 sec, 20–30 sec ISI |
150 | 12 (6 L, 6 R) | None | EEG event-related potentials (ERP) Accuracy, RT (Kanizsa), Abberant Behavior Checklist (ABC), Social Responsiveness Scale (SRS) (Caregiver- report), Repetitive Behav- ior Scale - Revised (RBS- R) |
Before and two weeks after treat- ment course |
Reduced error rate Increased frontal EEG N200 to targets Reduced frontal EEG N200 latency Increased frontal RHEEG P300 to targets Increased parietal EEG N200 to tar- gets, Reduced repetitive behavior (RBS) Reduced irritability (ABC) |
– |
Enticott et al. [2012], Brain Stimulation |
1 | 900 | 1 per site | Single | EEG movement-related corti- cal potentials Motor response time |
Before and after TMS | SMA: increased early EEG component PMC: increased EEG negative slope |
– |
Niederhofer [2012], Clin- ical Neuropsychiatry |
1 | 1200 | 5 | Single | Abberant Behavior Checklist (ABC) |
Before and after treatment course |
ABC Irritability: Active 40 to 33, Sham 39 to 35, ABC Sterotypy: Active 18 to 12, Sham 16 to 15 |
– |
Sokhadze et al. [2012], Applied Psychophysi- ology and Biofeedback |
15 × 10 sec, 20–30 sec ISI |
150 | 12 (6 L, 6 R) | None | EEG event-related potentials (ERPs) RT Accuracy (Kanizsa) |
Before and after treatment course |
Reduced omission error rates Increased EEG ERN amplitude Reduced EEG ERN latency |
– |
Panerai et al. [2013], Autism |
8 Hz 30 × 3.6 sec, 56.4 sec ISI |
900 | i) 3; ii) 10; iii) 5 active, 5 sham, 5 active, 5 sham; iv) 10 |
Double | (i), (ii), (iii), (iv) Psycho- educational Profile- Revised (PEP-R) eye-hand coordination; |
Before and after treatment course |
(i), (ii), (iii) improved eye-hand coordination score following lPrMC HF TMS iv) Improved eye-hand coordination score following com- bined TMS + EHI training compared to each technique alone |
– |
Enticott et al. [2014], Brain Stimulation |
30 × 10 sec, 20 sec ISI |
1500 | 10 | Double | Interpersonal Reactivity Index (IRI) Autism Spectrum Quotient (AQ) Ritvo Autism-Aspergers Diag- nostic Scale (RAADS) Reading the Mind in the Eyes Test (RMET) Mentalizing Animations Task |
Before, after, and one-month after treatment course |
Reduced social relatedness (RAADS) Reduced personal distress (IRI) |
1. “light- headedness” 2. facial discomfort during rTMS |
Cristancho et al. [2014], Journal of ECT |
(i) 15 × 10 sec, 10–30 sec ISI (week 1), 30 × 10 sec, 10–30 sec ISI (week 2), (ii) 30–60 × 10 sec, 10–15 sec ISI |
(i) 150–300, (ii) 300–600 |
(i) 10, (ii) 26 | None | Mental status examination | Before and after treatment course |
Anecdotal reports of improve mood, eye contact, interpersonal commu- nication, verbal expression, focus, activity |
Mild headaches, jaw twiching, tran- sient dizziness |
Casanova et al. [2014], Frontiers in Human Neuroscience |
8 × 10 sec, 20 sec ISI |
160 | 18 | None | Aberrant Behavior Checklist, restricted Behavior Pat- tern, Time- domain meas- ures of HRV (R-R interval, SDNN, RMSSD, pNN50), Frequency –domain meas- ures of HRV (LV and HF of HRV, LF/HF ratio index), SCL |
Before and 2 weeks after treatment |
Increase in R-R interval, SDNN, and HF power. Significant decrease in the LF/HF ratio and SCL. Signifi- cant improvements in RBS-R and ABC rating scores. |
None |
Sokhadze et al. [2014a], Frontiers in Systems Neuroscience |
9 × 20 sec, 20–30 sec ISI |
180 | 18 | None | Aberrant Behavior Checklist (ABC), Repetitive Behav- ior Scale (RBS-R), EEG event related potentials (ERPs), RT and post-error RT |
Before and after | Decreased irritability and hyperactiv- ity on the Aberrant Behavior Checklist (ABC), and decreased stereotypic behaviors on the Repetitive Behavior Scale (RBS-R). Decreased amplitude and pro- longed latency in the frontal and fronto-central N100, N200, and P300 (P3a) ERPs to non-targets. Increased amplitude of P2d (P2a to targets minus P2a to non-tar- gets) and centro-parietal P100 and P300 (P3b) to targets. Decrease in latency and increase in negativity of ERN during com- mission errors. |
None |
Sokhadze et al. [2014b], Appl Psychophysiol Biofeedback |
9 × 20 sec, 20–30 sec ISI |
180 | 18 | None | Aberrant Behavior Checklist, Repetitive Behavior Scale- Revised, EEG Gamma power, Theta/Beta ratio, RT and Accuracy, Post- error RT, EEG event related potentials (ERPs) |
Before and after | Integrated TMS-NFB treatment enhanced the process of target recognition. Significant improve- ments in RBS-R and ABC rating scores. Improvement in both early and later stage ERP indices. |
None |
ASD, Autism Spectrum Disorder; HFA, High Functioning Autism; AS, Asperger’s Syndrome; M1, Primary Motor Cortex; dlPFC, Dorsolateral Prefrontal Cortex; dmPFC, Dorsomedial Prefrontal Cortex; Fo8, Figure of 8 coil; ISI, Interstimulus Interval; rTMS, Repetitive Transcranial Magnetic Stimulation; RMT, Resting Motor Threshold.